Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bogoni (Verona, Italy), R. Guarise (Verona, Italy), A. Meschi (Verona, Italy), S. Tomezzoli (Verona, Italy), G. Zambito (Verona, Italy), A. Malvezzi (Verona, Italy), M. Sanguanini (Verona, Italy), A. Zanini (Verona, Italy), A. Borruso (Verona, Italy), M. Cipolli (Verona, Italy). Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre. 1267

Member's Comments

No comment yet.

Related content which might interest you: Inhaled mannitol as treatment for children with cystic fibrosis Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease Year: 2008 A ten year experience of non-cystic fibrosis bronchiectasis from a single center Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Optimising inhaled mannitol for cystic fibrosis in an adult population Source: Breathe 2015; 11:39-48 Year: 2015 The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Macrolides in cystic fibrosis (CF); clinical experience Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004 Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Evaluation of noncystic fibrosis bronchiectasis: six-year single center experience Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections Year: 2020 Non cystic fibrosis bronchiectasis in a pediatric clinic – 5 year evaluation Source: Eur Respir J 2006; 28: Suppl. 50, 490s Year: 2006 Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Cystic fibrosis: paediatric Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Cystic fibrosis: paediatric Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Cystic fibrosis: paediatric Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019